ABSTRACT. The immunoglobulin G (IgG) subclass response was investigated in horses with or without pyrexia after natural infection with equine herpesvirus type 1 (EHV-1) in the field. All horses were kept at the training centers of the Japan Racing Association and were immunized with an inactivated EHV-1 vaccine before EHV-1 infection. An IgG subclass response dominated by IgGa and IgGb was induced in horses without pyrexia after EHV-1 infection. In contrast, horses that developed pyrexia showed increased IgGc and IgG (T) subclass production in addition to IgGa and IgGb. Although inactivated EHV-1 vaccines are considered to induce a mainly Th-2-biased response, these results indicated that the responses in horses inoculated with inactivated EHV-1 vaccine were not uniform, and that horses with a Th-1-biased response were likely to be protected from pyrexia.
IgG subclass responses to infectious pathogens have been investigated in bacterial, viral, and protozoal infections in horses and are known to reflect host Th-1-or -2-type immunity [5, 7, 17, [20] [21] [22] [23] . Among the equine IgG subclasses, IgGa and IgGb are effective in both complement fixation and opsonization, and the IgG subclass response dominated by these two subclasses is regarded as a marker of a Th-1-type cellular immune response [10, 20] . In contrast, IgG(T) is associated with a Th-2-type response, which does not give effective protection against viral infection [10, 20] . Because only serum samples are required, the analysis of IgG subclass response is a convenient method of evaluating Th-1-and -2-type immune responses in a number of horses in the field.
Equine herpesvirus type 1 (EHV-1) is a major cause of respiratory disease [6] . Racehorses belonging to the Japan Racing Association are stabled into training centers at age 2 years, and most of them are infected with EHV-1 for the first time in their lives during their first winter there [14] . In contrast, almost without exception, the horses in the training centers are infected with EHV-4 before they are stabled, because this virus is endemic on breeding and rearing farms [14] . Horses previously infected with EHV-4 possess cross-neutralizing antibody against EHV-1, because these two viruses have extensive antigenic crossreactivity [8, 26] . Another factor that may influence the immune response against EHV-1 infection is vaccination. All 2-year-old horses in the training centers are immunized with inactivated EHV-1 vaccine (Nisseiken, Co., Ltd., Tokyo, Japan) between late autumn and winter (a maximum of three times, at 1-month intervals). Nevertheless, a number of cases of febrile illness caused by EHV-1 infection are recorded among horses in the training centers every winter [14, 24, 25] . It seems that the inactivated vaccine fails to induce the effective immune response required for protection from EHV-1-induced disease.
The relationship between a Th-1-biased immune response after EHV-1 infection and effective protection has been shown by experimental challenge studies [1, 10] . In horses with high counts of pre-existing cytotoxic T-cell precursors specific for EHV-1, the magnitude of viremia after EHV-1 challenge, and thus the subsequent development of neurologic disease, is likely to be controlled [1] . Another study revealed that horses treated with a modified live EHV-1 vaccine were protected from developing signs of nervous system involvement after EHV-1 challenge; they showed a Th-1-biased IgG subclass response [10] . In the same study, administration of inactivated EHV-1 vaccine induced a Th-2-biased IgG subclass response and failed to protect horses from developing signs of nervous system involvement [10] .
Other reports have also indicated that inactivated vaccines are weak inducers of cell-mediated immunity, which is required for protection from EHV-1-induced disease [2, 3, 16] . In light of these vaccine-trial studies, we speculated that horses immunized with inactivated EHV-1 vaccines in the field also show a Th-2-biased immune response after EHV-1 infection. However, immune responses in horses naturally infected with EHV-1 in the field have not yet been studied well. Here, we focused on the relationship between host Th-1-and -2-type immunity and clinical outcome in horses naturally infected with EHV-1 in the training centers. We analyzed the IgG subclasses in EHV-1-infected horses to clarify the differences in immune responses between horses with pyrexia and asymptomatic horses.
To identify EHV-1-infected horses, we collected sera from the Ritto and Miho training centers and subjected them to gG-ELISA, which can detect type-specific antibodies to EHV-1 and -4 [28, 29] . Briefly, Escherichia coli-expressed recombinant protein of the type-specific carboxyl terminal region of EHV-1 or -4 gG fused with glutathione S-transferase (GST) was used as an antigen [28] . Horseradish peroxidase (HRP)-conjugated goat anti-equine IgG polyclonal antibody (MP Biomedicals, Inc., Aurora, OH, U.S.A.) was used as a secondary antibody. The ELISA titer was expressed as the reciprocal of the maximum serum dilution that showed an absorbance difference of 0.1 or more between gG-GST fusion protein and GST protein. A virus neutralization (VN) test was performed with a 50%-plaque-reduction method by using EHV-1 89c25p strain and Madin-Darby bovine kidney cells, as described previously [13] . The statistical significance of the geometric mean (GM) titer was calculated by using Welch's t-test.
EHV-1-infected horses that did not show pyrexia were identified as follows. Two-to three-year-old Thoroughbreds were randomly selected at the Ritto and Miho training centers in winter 2006 to 2011 (n=719). Paired sera were collected at 9-to 30-day intervals (mean, 23.6 days). The horses were herded in healthy condition, with no obvious evidence of infection. Horses that fulfilled all the requirements described below were regarded as the "asymptomatic group": 1) EHV-1-gG-ELISA titer less than 1:200 in pre-sera; 2) a significant increase in EHV-1-gG-ELISA titer (more than 1:400 in post-sera); 3) no significant increase in EHV-4-gG-ELISA titer between the paired sera; and 4) no pyrexia (≥38.5°C) during the sampling period. In total, we identified 9 out of 719 horses that had become infected with EHV-1 but had no pyrexia or concurrent active infection with EHV-4.
Horses with EHV-1 infection and pyrexia were identified as follows. In winter 2007 to 2010, at both training centers, paired sera (n=251) were taken from 2-to 3-year-old Thoroughbreds showing pyrexia (≥38.5°C). Pre-sera were taken on the day when pyrexia was detected, and post-sera were taken at 20-to 30-day intervals (mean, 23.9 days). From the results of the EHV-1-and EHV-4-gG-ELISA, we identified 60 horses that had become infected with EHV-1 and that had pyrexia but no concurrent active infection with EHV-4. From this population, we randomly selected 18 horses and designated them as the "pyretic group."
All horses in the two groups were immunized with inactivated EHV-1 vaccine (Nisseiken, Co., Ltd.) at least once (maximum, three times) before collection of the pre-sera. The horses had a history of previous infection with EHV-4, because they had titers of 1:4,000 or more in their pre-sera upon EHV-4-gG-ELISA (data not shown).
The IgG subclass response to EHV-1 was measured by using ELISA based on EHV-1-specific gG-ELISA, as described previously [4, 17] . We used the recombinant gG protein as an antigen for a precise evaluation of IgG subclass responses, because it reacts with antibodies induced by EHV-1 infection specifically, and not with antibodies induced by EHV-4 infection nor inactivated EHV-1 vaccine immunization [29] . HRP-conjugated goat anti-equine IgG subclass-specific polyclonal antibodies (Bethyl Laboratories, Inc., Montgomery, TX, U.S.A.) were used as secondary antibodies for the detection of the IgGa, IgGb, IgGc, and IgG(T) subclasses. ELISA titers were expressed as described above. According to the latest nomenclature of equine IgG subclasses based on the IgG heavy chain gene loci, the originally described IgG subclasses were designated as follows: IgGa corresponds to IgG1, IgGb to IgG4 and IgG7, IgGc to IgG6, and IgG(T) to IgG3 and IgG5 [12, 27] . However, the secondary antibodies which we used are based on the original nomenclature [anti-IgGa, -IgGb, -IgGc and -IgG(T)]. The anti-IgGb antibody cannot differentiate IgG4 and IgG7. So in the case of anti-IgG(T) antibody which reacts with both IgG3 and IgG5. Therefore we describe the IgG subclasses with the original nomenclature throughout the manuscript. The IgG subclass responses of the two groups were indicated in Tables 1 and 2 , and the total numbers of horses which showed increased titers in each subclass were summarized in Table 3 . Increases in the titers of IgGa and IgGb (more than 2-fold) were similar in the two groups (Tables  1 and 2 ). IgGa titers were increased in 6 of the 9 horses in the asymptomatic group and 17 of the 18 horses in the pyretic group. IgGb titers were increased in all horses in both groups (Table 3) . This was consistent with our previous data showing that production of these two subclasses is induced in almost all horses infected with EHV-1 [4] . IgGc and IgG(T) responses were entirely undetectable in the asymptomatic group (Table 1) , whereas some horses in the pyretic group showed an increase in IgGc and/or IgG(T) titers (Table 2 ). Seven horses in the pyretic group had increased IgGc titers in their post-sera. Increased IgG(T) titers in the post-sera were found in 14 out of 18 pyretic horses (Table 3 ). These results indicated that the horses without pyrexia after infection with EHV-1 developed a Th-1-biased immune response, which was characterized by a dominance of IgGa and IgGb subclasses. Because IgGa and IgGb are essential for virus neutralization, production of these two subclasses should be of benefit for a protection from clinical signs [15, 18] . In contrast, the horses with pyrexia developed a Th-2-biased immune response characterized by increased titers of IgG(T) in addition to IgGa and IgGb. Production of IgGc and IgG(T) in this latter group could be one explanation for the pyrexia, because these two subclasses do not have complement-fixing activity and can disturb complement fixation by IgGa and IgGb [15, 18] . Although all horses in the two groups were thought to have been infected with EHV-1 for the first time, two horses in the pyretic group had IgGc titers of 1:800 or more in their pre-sera (Table 2) . A similar observation has been reported for the IgG(T) subclass: ponies with no history of previous exposure to EHV-1 or vaccination had pre-existing titers to IgG(T), and the origin of the IgG(T) was not elucidated [9] . We could not find a clear explanation for the origin of the pre-existing IgGc, because the role of IgGc, which is a minor equine IgG subclass, has not been defined in any condition.
VN antibody titers in the pre-sera varied from 1:10 to 1:80 in the asymptomatic group (GM, 20.00, Table 1 ) and from 1:5 to 1:40 in the pyretic group (GM, 11.67, Table 2 ). Although this difference was not significant (P=0.23), the higher levels of VN antibodies in the asymptomatic group might have contributed to the suppression of viral replication. A significant increase (more than 4-fold) in post-sera VN titers was observed in 6 out of 9 horses in the asymptomatic group and in all horses in the pyretic group. The GM titer of VN in the post-sera of the asymptomatic group was 93.32-significantly lower than that in the pyretic group (244.39, P<0.05). The lower post-sera titers in the asymptomatic horses may reflect greater suppression of virus replication than in the pyretic group. This result supports previous conclusions that increased VN antibody titers in the post-sera are not correlated with protection from the development of severe clinical signs [2, 11, 19] . A similarity of IgGa and IgGb responses to VN titer responses after EHV-1 vaccination was previously reported, and they used complete virions as an antigen for the IgG subclass determination [9, 10] . However, our results showed no apparent relationship between these IgG subclasses and the VN titers (Tables 1 and 2 ), probably because the antigen which we used in the ELISA was not complete virions but the recombinant gG protein.
Although all horses that we investigated were inoculated with inactivated EHV-1 vaccine before EHV-1 infection, the horses in the asymptomatic group developed a clearly Th-1-biased response. We therefore consider that the cause of the Th-1-biased response in these horses was not the vaccination. One possible explanation for the different immune responses between the two groups is differences in the history of previous exposure to EHV-4, which induces cross-protective immunity to EHV-1. As we demonstrated in a previous study, horses previously infected with EHV-4 developed a more Th-1-biased IgG subclass response against subsequent infection with EHV-1 than did those naïve to EHV-1/4 [4] . In this study, EHV-4-specific gG-ELISA indicated that all horses had a history of previous EHV-4 infection. However, the number and timing of EHV-4 infections in each horse were not clear. Horses repeatedly infected with EHV-4, or those infected just before the sampling period, might have shown a more Th-1-biased response to EHV-1 than those infected only once or infected a long time before the sampling period; the former group might have been better protected from pyrexia.
In conclusion, a Th-1-biased immune response appears to mitigate clinical signs after EHV-1 infection. However, some horses in the pyretic group also developed an IgGsubclass response dominated by IgGa and IgGb. This result indicated that a Th-1-biased subclass response was not the only requirement for protection. A higher VN antibody titer in the asymptomatic group at the time of EHV-1 infection might be a co-factor contributing to the mitigation of clinical signs. Further unknown factors might play roles in the development of clinical signs. Because of difficulty in collecting samples from a number of horses in the field, we were unable to monitor direct markers of cell-mediated im- Numbers of horses which showed seroconversion or increased titers (more than 2-fold) in each subclass were indicated.
